Pharmacodynamic modelling reveals synergistic interaction between docetaxel and SCO-101 in a docetaxel-resistant triple negative breast cancer cell line. [electronic resource]
Producer: 20210104Description: 105315 p. digitalISSN:- 1879-0720
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Docetaxel -- pharmacology
- Drug Interactions
- Drug Synergism
- Female
- Humans
- Triple Negative Breast Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.